Patents by Inventor Ronald Bracken

Ronald Bracken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11253634
    Abstract: This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: February 22, 2022
    Assignee: BRIGHAM YOUNG UNIVERSITY
    Inventors: Paul B. Savage, Carl Genberg, Ronald Bracken
  • Publication number: 20190365560
    Abstract: This disclosure relates to deodorizing compositions, ostomy devices, and uses thereof. In certain embodiments, the disclosure contemplates a deodorizer comprising a combination of citric acid and a citric acid salt, cocamidopropyl betaine, zinc ricinoleate, and optionally comprising a preservative such as a paraben. In certain embodiments, the deodorizing composition is contained loaded in a hydrogel or hydrophilic polyurethane. In further embodiments, the loaded hydrogel or hydrophilic polyurethane is placed in an ostomy device.
    Type: Application
    Filed: December 7, 2017
    Publication date: December 5, 2019
    Inventors: Cynthia Timms, Ronald Bracken
  • Publication number: 20190076581
    Abstract: This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Inventors: Paul B. Savage, Carl Genberg, Ronald Bracken
  • Patent number: 10226550
    Abstract: This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: March 12, 2019
    Assignee: BRIGHAM YOUNG UNIVERSITY
    Inventors: Paul B. Savage, Carl Genberg, Ronald Bracken
  • Publication number: 20170258963
    Abstract: This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 14, 2017
    Applicant: BRIGHAM YOUNG UNIVERSITY
    Inventors: Paul B. Savage, Carl Genberg, Ronald Bracken
  • Publication number: 20070231391
    Abstract: An antimicrobial and hydrophilic article that is microbial resistant comprises an antimicrobial agent and a hydrophilic agent combined with a base material. The combination can be extruded, calandarized, or molded to form the medical article, ensuring that the anti-microbial properties are not localized at the surface. The entire bulk of the article, including the surface thereof, is capable of having anti-microbial characteristics, allowing refreshening of the surface with time.
    Type: Application
    Filed: October 3, 2006
    Publication date: October 4, 2007
    Applicant: C.R. Bard, Inc.
    Inventors: Ronald Bracken, James Lambert, Gregory Mann